Generation Lab Raises $11M Seed Round for SystemAge Longevity Platform

October 29, 2025
Generation Lab has raised $11 million in seed funding led by Accel to expand its SystemAge platform, which measures biological aging across 19 organ systems using blood data.

San Francisco-based Generation Lab has raised $11 million in seed funding to expand its SystemAge platform, announced in a press release. The round was led by Accel, with participation from Samsung Next, Zone2, Aoki Labs, BYL Ventures, and Markham Valley Ventures. The new funding brings Generation Lab’s total capital raised to $15 million.

Launched less than a year ago, SystemAge quantifies biological age by analyzing 19 organ systems through primary blood data. The company reports over 275 clinical partnerships and 300 million human-aging data points collected to date. Generation Lab claims a diagnostic accuracy of 99.9% for its system, which is used by academic medical centers, wellness clinics, and professional athletes.

SystemAge uses proprietary algorithms to measure biological aging and identify which organ systems are aging most rapidly. Clinical data cited by the company show measurable reversals in biological age following interventions such as stem cell therapy, diet changes, and exercise regimens. Generation Lab plans to use the new funding to expand access to its longevity diagnostics globally.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

10/29
ATDev Raises $3 Million Seed Funding to Expand Assistive Mobility Ecosystem
10/29
The Bot Company Plans $250 Million Raise at $4 Billion Valuation
10/29
Fourier Health Raises $8.4M to Streamline Clinical Data Processing with AI
10/29
Novartis to Acquire Avidity Biosciences for $12 Billion
10/29
Opyn Health Acquires AI Benefits Platform Empara

More from: Life Sciences

10/29
ExaCare AI Raises $30M Series A to Expand AI Platform for Skilled Nursing Facilities
10/29
Harbour BioMed Launches Fully Human Generative AI HCAb Model
10/29
MCG Health and Allegheny Health Network to Present on AI in Utilization Management at ACMA 2025
10/29
CareSet Names Sepideh Naseri Chief Data and Analytics Officer
10/29
ID.me and Flexpa Partner to Strengthen Health Data Access and Security

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like